TCG Crossover Management »

Perspective Therapeutics shares owned by TCG Crossover Management

Quarter-by-quarter ownership of Perspective Therapeutics (CATX) shares owned by TCG Crossover Management from 13F filings

Historical chart of TCG Crossover Management investment in Perspective Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Perspective Therapeutics held by TCG Crossover Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Perspective Therapeutics by TCG Crossover Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $33M 7.9M 4.17

More positions owned by TCG Crossover Management

Abivax Sa American Depositary Shares Adrs (ABVX)
Cg Oncology Comm (CGON)
Tango Therapeutics Comm (TNGX)
Cogent Biosciences Comm (COGT)
Centessa Pharmaceuticals Adrs (CNTA)
Dianthus Therapeutics Comm (DNTH)
Tyra Biosciences Comm (TYRA)
Immunovant Comm (IMVT)
Biocryst Pharmaceuticals Comm (BCRX)
Mirum Pharmaceuticals Comm (MIRM)
Vor Biopharma Comm (VOR)
Spyre Therapeutics Comm (SYRE)
Amylyx Pharmaceuticals Comm (AMLX)
Disc Medicine Comm (IRON)
Dyne Therapeutics Comm (DYN)

View all positions for TCG Crossover Management

Top funds holding Perspective Therapeutics

TCG Crossover Management
Commodore Capital
Avidity Partners Management
BlackRock
Opaleye Management
Vanguard Capital Management
Millennium Management
Citadel Advisors
Vanguard Group
Balyasny Asset Management
Morgan Stanley
Geode Capital Management
Patient Square Capital
Nicholson Wealth Management Group
Goldman Sachs Group

View all funds holding Perspective Therapeutics